Back
BriaCell Therapeutics Corp. 10K Form
Sell
20
BCTX
BriaCell Therapeutics Corp.
Last Price:
$9.00
Seasonality Move:
3384.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BCTX News And Ratings
See the #1 stock for the next 7 days that we like better than BCTX
BCTX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-7.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.30 |
| Price / Book: | 1.57 |
Profitability
| EPS (TTM): | -48.35350 |
|---|---|
| Net Income (TTM): | $-29M |
| Gross Margin: | $-106.6K |
| Return on Equity: | -318.28% |
| Return on Assets: | -202.82% |
BriaCell Therapeutics Corp. Earnings Forecast
Key BriaCell Therapeutics Corp. Financial Ratios
-
Per Share Earnings over the last 20 years have been positive in 10 years.
BriaCell Therapeutics Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BCTX |
| Website: | briacell.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.42 |
| Quick Ratio: | 3.07 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BCTX Technical Analysis vs Fundamental Analysis
Sell
20
BriaCell Therapeutics Corp. (BCTX)
is a Sell
Is BriaCell Therapeutics Corp. a Buy or a Sell?
-
BriaCell Therapeutics Corp. stock is rated a SellThe current BriaCell Therapeutics Corp. [BCTX] share price is $8.95. The Score for BCTX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.